Myriad Genetics Acquires Sividon Diagnostics
With Sividon’s breast cancer prognostic test, Myriad aims to strengthen its oncology product portfolio.
Read MorePosted by Elaine Sanchez Wilson | Jun 7, 2016 | Company News, Molecular Diagnostics |
With Sividon’s breast cancer prognostic test, Myriad aims to strengthen its oncology product portfolio.
Read MorePosted by Elaine Sanchez Wilson | Jun 2, 2016 | Cancer, Molecular Diagnostics |
The recent FDA premarket approval for the Epi ProColon colorectal cancer screening test by Epigenomics AG highlights the potential of liquid biopsy methods.
Read MorePosted by Elaine Sanchez Wilson | May 16, 2016 | Research |
Two recent studies have demonstrated the benefits of molecular testing in pediatric cases of thyroid lesions.
Read MorePosted by Elaine Sanchez Wilson | May 16, 2016 | Research |
A new study shows that Zika virus infects and crosses the placentas of pregnant mice, and causes severe damage or death in fetal mice
Read MorePosted by Elaine Sanchez Wilson | May 11, 2016 | Disease States |
Advances in testing techniques are being predicted as moonshot byproducts.
Read More